Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE HCV Study
2017-001039-38Phase 2Completed
- Sponsor
- University of Dundee
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of grazoprevir, sofosbuvir in hepatitis C virus infection, sponsored by University of Dundee. Started May 2018; status: completed.
02
Drugs
grazoprevirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2017-001039-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001039-38.